Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Circularity Index as a Risk Factor for Progression of Geographic Atrophy

Go back to Resources

Circularity Index as a Risk Factor for Progression of Geographic Atrophy

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report

Go back to Resources

Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report

Authors:

Secondary:

URL:

Abstract:

Go back to Resources

Changes in Clearance, Volume and Bioavailability of Immunosuppressants When Given With HAART in HIV-1 Infected Liver and Kidney Transplant Recipients

Go back to Resources

Changes in Clearance, Volume and Bioavailability of Immunosuppressants When Given With HAART in HIV-1 Infected Liver and Kidney Transplant Recipients

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Body Mass Index (BMI) and Obesity Prevalence Among Substance Abuse Participants from NIDA’s Clinical Trials Network (CTN)

Go back to Resources

Body Mass Index (BMI) and Obesity Prevalence Among Substance Abuse Participants from NIDA’s Clinical Trials Network (CTN)

Authors:

Secondary:

Location:

URL:

Abstract:

Go back to Resources

Validation of a Genomic Classifier That Predicts Metastatic Disease Rogression in Men with Biochemical Recurrence Post Radical Prostatectomy

Go back to Resources

Validation of a Genomic Classifier That Predicts Metastatic Disease Rogression in Men with Biochemical Recurrence Post Radical Prostatectomy

Authors:

Secondary:

Location:

URL:

Abstract:

Go back to Resources

Validation of a Genomic Classifier that Predicts Metastatic Disease Progression in Men with High-Risk Pathologic Features Postprostatectomy

Go back to Resources

Validation of a Genomic Classifier that Predicts Metastatic Disease Progression in Men with High-Risk Pathologic Features Postprostatectomy

Authors:

Secondary:

Location:

URL:

Go back to Resources

Validation of A Genomic Classifier That Predicts Metastatic Disease Progression in Men With Biochemical Recurrence Post Radical Prostatectomy

Go back to Resources

Validation of A Genomic Classifier That Predicts Metastatic Disease Progression in Men With Biochemical Recurrence Post Radical Prostatectomy

Authors:

Secondary:

Location:

URL:

Go back to Resources

Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an at Risk Patient Population

Go back to Resources

Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an at Risk Patient Population

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Use of the National Cancer Institute Community Cancer Centers Program Screening and Accrual Log to Address Cancer Clinical Trial Accrual

Go back to Resources

Use of the National Cancer Institute Community Cancer Centers Program Screening and Accrual Log to Address Cancer Clinical Trial Accrual

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Two Dimensional Echo Methods for Right Atrial Volume Assesment: Accuracy and Performance Using MRI as Reference

Go back to Resources

Two Dimensional Echo Methods for Right Atrial Volume Assesment: Accuracy and Performance Using MRI as Reference

Authors:

Secondary:

Location:

URL:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 210
  • Page 211
  • Page 212
  • Page 213
  • Current page 214
  • Page 215
  • Page 216
  • Page 217
  • Page 218
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification